Australia has witnessed a significant increase in ADHD prescriptions, with a 25% year-over-year rise in 2025. This surge has prompted concerns among doctors and regulators regarding the role of telehealth in diagnosing ADHD and the potential impact on the National Disability Insurance Scheme (NDIS).
ADHD Prescription Trends
The number of Australians taking ADHD medications has reached nearly 1 million, with 837,937 patients receiving 6.7 million scripts in 2025. This trend has raised questions about the accuracy of telehealth diagnoses and the potential consequences for the NDIS.
Australia sees 25% rise in ADHD prescriptions, sparking concerns over telehealth diagnoses and NDIS cost impacts.
Telehealth Diagnoses Under Scrutiny
The increase in ADHD prescriptions has led to scrutiny of telehealth diagnoses, with some experts expressing concerns about the potential for misdiagnosis or overdiagnosis. The Australian government has announced plans to review the use of telehealth in ADHD diagnoses.
The rise in ADHD prescriptions is a wake-up call for us to re-examine our approach to diagnosis and treatment.
Laura Lurns · Learning Success expert
NDIS Cost Impacts
The rise in ADHD prescriptions has also sparked concerns about the potential cost impacts on the NDIS. The scheme provides funding for Australians with disabilities, and the increasing number of ADHD diagnoses could put a strain on resources.
Key takeaways
- ADHD Prescription Rise: 25% year-over-year increase in ADHD prescriptions in Australia.
- Telehealth Diagnoses: Scrutiny over the accuracy of telehealth diagnoses.
- NDIS Cost Impacts: Potential strain on NDIS resources due to increasing ADHD diagnoses.
Looking Ahead
As the Australian government reviews the use of telehealth in ADHD diagnoses, it is essential to consider the potential consequences for the NDIS and the impact on individuals and families affected by ADHD. By understanding the complexities of ADHD and its diagnosis, we can work towards creating a more effective and sustainable support system.
By understanding the complexities of ADHD and its diagnosis, we can work towards creating a more effective and sustainable support system. The Learning Success All Access Program offers a free trial that includes a personalized Action Plan, empowering parents to take control of their child’s learning journey.
See what All Access gives your child
Explore Focus Foundations
Is your child struggling in school?
Get your free personalized learning roadmap
You describe what you see at home. We turn it into a plan you start this week.
- Answer 5 short questionnaires about what you already notice, 30–45 minutes at your own kitchen table
- Your child sits no test and gets no score: nothing to schedule, nothing for them to dread
- You do the answering, the AI does the writing, and a person reviews it before it reaches you
- Access all 40+ courses instantly: reading, math, focus, processing and more, with new ones added regularly
Why we use AI, plainly: it writes from a knowledge base our team maintains and audits. We work through it line by line and pull anything the evidence stops supporting. The roadmap you get on Tuesday reflects what we corrected on Monday, and a human still reads it before you do.
Your school district must evaluate your child free of charge if you ask in writing, whatever your income and whatever the outcome (US, 34 CFR 300.111 and 300.301(b)). That route takes time and answers a different question than you do. This one starts today, from what you already know.
Your answers stay yours. We do not sell your personal information, and we do not hand identifiable assessment data to outside AI companies to train their models.
A screener is a starting point, not a diagnosis. If your child might need formal accommodations (an IEP or 504 plan), or you suspect a vision, hearing or medical cause, pursue a professional evaluation too. That is the only route to those supports.
References
